Evidence map›Paper›PMID 40743397›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

SMARCA5 restricts chromatin accessibility to promote male meiosis and fertility in mammals.

Shubhangini Kataruka, Aushaq B Malla, Shannon R Rainsford, Benjamin William Walters, Rachel A Heuer, Kira L Marshall, Bluma J Lesch

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Meiotic prophase I disruption as a strategy for nonhormonal male contraception using small-molecule inhibitor JQ1.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Shubhangini Kataruka *Department of Genetics, Yale School of Medicine, New Haven, CT 06510.ORCID 0000-0002-1303-6390
Aushaq B Malla *Department of Genetics, Yale School of Medicine, New Haven, CT 06510.ORCID 0000-0001-5733-6523
Shannon R RainsfordDepartment of Genetics, Yale School of Medicine, New Haven, CT 06510.
Benjamin William WaltersDepartment of Genetics, Yale School of Medicine, New Haven, CT 06510.ORCID 0000-0003-3375-8590
Rachel A HeuerDepartment of Genetics, Yale School of Medicine, New Haven, CT 06510.
Kira L MarshallDepartment of Genetics, Yale School of Medicine, New Haven, CT 06510.
Bluma J LeschDepartment of Genetics, Yale School of Medicine, New Haven, CT 06510.ORCID 0000-0002-6689-0240

Funding

GENETICS AND GENOMICS OF HUMAN DISEASET32HD007149 · NICHD · YALE UNIVERSITY · PI James P Noonan · 1985 to 2026
$8.2M
Germline Utx mutation as a model for transgenerational epigenetic inheritanceR01HD098128 · NICHD · YALE UNIVERSITY · PI LESCH, BLUMA J · 2020 to 2024
$2.0M
High Performance Computing Instrumentation for the Yale Center for Genome AnalysisS10OD030363 · OD · YALE UNIVERSITY · PI MANE, SHRIKANT M · 2022 to 2022
$1.2M
6500 QTrap Mass Spectrometer for Yale UniversityS10OD018034 · OD · YALE UNIVERSITY · PI MANE, SHRIKANT M · 2014 to 2014
$514k
Defining the role of DOT1L in chromocenter stabilization pre- and post-fertilizationR21HD110843 · NICHD · YALE UNIVERSITY · PI LESCH, BLUMA J · 2023 to 2023
$461k
Defining signatures of epigenetic sensitization to lung cancer in a mouse modelR21CA288677 · NCI · YALE UNIVERSITY · PI LESCH, BLUMA J · 2024 to 2025
$430k
An Ultra-Performance Liquid Chromatography System to Support Metabolomics at Yale UniversityS10OD019967 · OD · YALE UNIVERSITY · PI LAM, TUKIET T · 2015 to 2015
$135k
HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) R01HD098128HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) R21HD110843HHS | NIH | National Cancer Institute (NCI) R21CA288677NCI NIH HHS R21 CA288677NICHD NIH HHS R01 HD098128NICHD NIH HHS R21 HD110843NICHD NIH HHS T32 HD007149NIH HHS S10 OD018034NIH HHS S10 OD019967NIH HHS S10 OD030363Pew Charitable Trusts (PEW) GR-000010761Surdna Foundation (SF) NA
6 · The paper itself

Abstract

Establishment of correct chromatin configuration in male meiosis is essential for sperm formation and male fertility. However, how chromatin remodeling contributes to meiotic progression in male germ cells is not well understood. Here, we find that the ISWI family ATP-dependent chromatin remodeling factor SMARCA5 (SNF2H) plays a critical role in regulating meiotic prophase progression during spermatogenesis in mice. Male mice with germ cell-specific depletion of SMARCA5 are infertile and unable to form sperm. Conditional knockout of

Indexed as

ChromatinChromosomal Proteins, Non-HistoneFertilityMeiosisAdenosine TriphosphatasesAnimalsChromatin Assembly and DisassemblyDNA RepairInfertility, MaleMaleMiceMice, KnockoutSpermatocytesSpermatogenesisTestisAdenosine TriphosphatasesChromatinChromosomal Proteins, Non-HistoneSmarca5 protein, mousechromatinfertilitygene regulationgerm cellsspermatogenesis

Identifiers

PMID40743397
PMCPMC12337329

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.